Value-based care initiatives and ideas have really been growing over the past few years, with outcome-based arrangements being one of the newest ideas. Could this be the year it all takes off? Find out more here. (Source: Matthew Fisher, HiMSS, Linkedin) […]
Could AI Take the Place of Your Doctor?
Computer algorithms may soon outperform human pathologists in both accuracy and speed, but rather than letting artificial intelligence (AI) take over the field, two pathology professors from Yale believe that AI will instead emerge as a powerful tool. Find out more here. (Source: Evan Sweeney, […]
Six Healthcare Trends to Watch in 2018
2018 finds the U.S. health care industry on the edge of significant change. Despite shifting market trends and business realities, this article feels confident in making some predictions on what we may see in healthcare for 2018. Read more here. (Source: Health Affairs Blog, 1/29/18) […]
NPC Launches Initiative to Explore Health Care Spending
The National Pharmaceutical Council recently launched a new research-first initiative, Going Below the Surface. The initiative intends to seek constructive answers on how we can spend our health dollars more effectively. Will they be able to move past all the finger pointing? Find out more here. […]
New Book: “How Economics Professors Can Stop Failing Us: The Discipline at a Crossroads”
This book provides an eye-opening exposé on economics professors that will surely shock anyone who is not familiar with the topic, and even some of those who are familiar with it. It is critical of the behavior of economics professors, but is not critical of the field of economics itself. In fact, […]
Are Rebates Saving You Money? or Costing You More?
Pharmaceutical companies often argue that the list price for their products doesn't really matter because that's not the real price that anybody pays, however, the truth is, it does matter. High list prices drive patients into and out of the dreaded "doughnut hole" faster, raising both their […]
CancerLinQ Collaborates with Vector Oncology
Vector Oncology recently announced two key agreements with CancerLinQ aimed to improve both cancer care and patient outcomes. Find out more details here. (Source: Vector Oncology, 5/31/17) […]
Evidera – Looking for a Medical Writer
Evidera is looking to fill a position in Medical Writing and Communications. Location may be based on your experience and qualifications! Find out more about this job posting and many others in this week's HealthEconomics.Com Jobs Newsletter, your connection to the latest job openings in the Health […]
WHO Commits to Biosimilar Medicine Prequalification Program
The World Health Organization (WHO) is planning on launching a new pilot program, a Biosimilar Medicine Prequalification Program, to assess cheap copies of expensive biotech cancer drugs, making these medicines more widely available. Find out more here. (Source: dispatch tribunal, 5/8/17) […]
Lets Take a Look at Healthcare Reform Outside the U.S.
America's healthcare system is surrounded with questions. Questions about who should be covered, how much it should cost, who should pay? As the healthcare system in American tries to find direction and answer these questions, lets take a look at how some other countries have answered them and what […]
Stay In-the-Know with HE.Com’s Weekly Newsletter
Don't miss out on $30M in grant opportunities, a new value framework for diagnostics, a bipartisan bill to justify pharmaceutical price hikes and more! It's all in this weeks HealthEconomics.Com's weekly newsletter, available here. If you would like to receive our newsletter every week in your […]
How Does One Possibly Pay for a $1M/month Treatment?
Wellmark Blue Cross & Blue Shield is planning on raising premiums a good 38-43% in the next year for about 30,000 of their customers. While explaining the premium increase, 10 percentage points were attributed to the cost of a single, extremely complicated patient whose severe genetic disorder […]
Navigating to Value in Healthcare
Where data already exist, many healthcare leaders don't know how to find, retrieve, organize and leverage them for their needs. Navigating to Value in Healthcare author Thom Walsh, PhD, creates an antidote for this situation. You'll learn how to create systems and processes that help to leverage […]
Book Release: The Future of Health Economics
The Future of Health Economics offers a window into some of the most influential emerging issues in pharmacoeconomics, including risk-sharing, alternative pricing models, personalized medicine, and the changing role of government and regulators. Ulf Staginnus and Olivier Ethgen, themselves two of […]
After the Co-Pay, Who Pays for Your Prescription Drugs?
When you pick up your prescription at the pharmacy and pay your co-pay, do you ever wonder what happens next? Who pays the remaining cost? the insurer right? This article and accompanying graphic take you through the process of pricing a pharmaceutical, purchase and reimbursement, and there's more […]
New Study Highlights Trumpcare’s Damage
The decade old health insurance expansion in Massachusetts has turned out to be a well-timed experiment offering real-world evidence as to a post Trumpcare healthcare system. This Massachusetts data is more concrete than an analysis from the Congressional Budget Office (CBO) would be and makes the […]
Evidera Seeks Senior Research Associate – London
Evidera is searching for a Senior Research Associate - Patient Reported Outcomes, for their London location. Find out more on this job post and others in HealthEconomics.Com's New Jobs Portal, your premier employment source for HEOR, Market Access, and Real World Evidence. You can get a list of our […]
Don’t Miss ISPOR’s HEOR Hands-on Training Course!
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has planned a HEOR Short Course Program to take place during their 22nd Annual International Meeting to be held in Boston, MA, USA, May 20-24, 2017. Register for this hands-on training course here. (Source: ISPOR, 2017) […]
RWD Differences Across 6 European HTAs
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s Value in Health recently published a new study revealing notable differences in how European health technology assessment (HTA) agencies assess real-world data. Find out more here. (Source: ISPOR) […]
Blended Learning MSc Opportunities at Lancaster University
The new Blended Learning MSc in Health Economics and Policy meets the needs of those wishing to enhance their research skills, develop their understanding of theory, policy and practice, and make an original contribution to knowledge development within their field, while at the same time fulfilling […]
Desperate Diabetics Seek Black Market Insulin
Imagine not being able to afford the life saving medicine for your child needs. Imagine finding a way in which you could get the medicine, but not without potential risks. How high are the risks? Does it matter? Find out more about Families, so desperate, they're looking to the Black Market to get […]
HE.Com’s Weekly News is Here! What Did You Miss?
What impact will ICER reports have in Europe? Should value frameworks for rare disease be different? How is the current uncertainty in healthcare affecting you? Could your advisory board benefit from a medical writer? Read more about all of these topics and more in HealthEconomics.Com's latest […]
Pharmacy Schools Offering HEOR Fellowships
The push for value-based medicine has given the field of health economics and outcomes research (HEOR) traction and has led to fellowships and training in the field of pharmacoeconomics and outcomes research. Virginia Commonwealth University is the latest to offer a post-doctoral fellowship in […]
Stephen Parente Nominated as HHS Deputy Secretary
Stephen Parente was recently nominated to be HHS' assistant secretary of planning and evaluation, a principal advisor to HHS Secretary Dr. Tom Price. Parente has been outspoken about the ACA, even predicting it's collapse back in 2014. Read more here. (Source: Dave Barkholz, 4/10/17) […]
McCann Health Welcomes Two New Managing Directors
McCann Health is expanding on various projects and has appointed two new managing directors to the firm as a result. Please join us in welcoming Robert Paglia and Randy Goodman to the McCann Health Team! You can find out more about their experience here. (Source: PMLiVE, 4/11/17) […]
PIE Legislation Officially Introduced in Congress
The Pharmaceutical Information Exchange (PIE) Act of 2017 has recently been introduced by Rep. Brett Guthrie (R-KY). This bill aims to improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between […]
Are You Ready for a Career Move?
This week's HealthEconomics.Com Jobs Newsletter has new jobs posted this week from Eli Lilly, Pharmerit and more! Could they be looking for you? Every week, HE.Com sends out a newsletter connecting you with the latest career opportunities in the field, as well as upcoming events! You can find out […]
Can We Celebrate Saving Lives as We Destroy Them?
Pharmaceutical pricing has been all over the news and, if you're sick, could be more than just an issue of morality - it could be a matter of life and death. Profiteering by unscrupulous pharmaceutical companies goes to a whole new level when it comes to orphan drugs. Take Biogen's recent pricing […]
Payers Not Interested in HEOR Measures
Research data released by inVentiv Health found that 92% of private payers are not interested in seeing a larger use of PROs in clinical trials. Another 70% of interviewed payers said they are only confident in HEOR produced when it is supported by a neutral organization or institution. Read more […]
Why are so Many Brokers Leaving HealthCare.gov?
More and more insurance companies are refusing to pay commissions to insurance brokers selling individual market plans, causing many to exit HealthCare.gov. This move could potentially leave consumers with lower quality coverage or none at all. Login to read more. (Source: Modern Healthcare) […]
